Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine Dose Effects on Prevention of Propofol Injection Pain
ChiCTR-IPR-17011234Phase 4Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- May 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dezocine in propofol injection site pain (PISP) (5 arms), sponsored by Fudan University Shanghai Cancer Center. Primary endpoint: Propofol injection pain score. Started May 2017; status: completed.
02
Drugs
dezocine
03
Conditions
propofol injection site pain (PISP)
Beyond the preview
Go deeper on ChiCTR-IPR-17011234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011234.